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CELL-MEDIATED  LYMPHOLYSIS  OF 
TRINITROPHENYL-MODIFIED  AUTOLOGOUS  LYMPHOCYTES 
Confirmation of Genetic Control of 
Response to Trinitrophenyl-Modified H-2 Antigens by the Use 
of Anti-H-2 and Anti-Ia Antibodies 
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(From the  Immunology Branch, National  Cancer  Institute,  National  Institutes  of  Health,  Bethesda, 
Maryland 20014) 
The in vitro induction of T-cell-mediated lympholysis (CML) to trinitrophenyl (TNP)- 
modified  autologous  spleen  cells  has  been  demonstrated  in  the  mouse  (1). Lysis of 
modified splenic target cells was obtained when there was K  or D  serological region 
homology between the target cells and the cells used in the  sensitizing phase  (2,  3). 
Experiments using F~ responding lymphocytes sensitized and assayed with TNP-modified 
parental cells indicated that homology between effector and target cells was not sufficient 
to obtain lysis, but that the homology required was either between modified stimulating 
and modified target cells, or among responding, modified stimulating and modified target 
cells (2). These findings are compatible with the hypothesis that TNP is modifying cell 
surface components controlled by the K and D serological regions of the major histocom- 
patibility complex, and that the responding lymphocytes are reacting against these new 
antigenic specificities. 
Earlier studies have shown that sensitization of B10.A responding lymphocytes with 
TNP-modified autologous spleen cells generated effector cells which lysed TNP-modified 
K-end-matched target cells, but not TNP-modified D-end-matched targets (2, 4).  This 
finding contrasts with the results obtained with B10.D2 effector cells which lysed TNP- 
modified H-2K- and H-2D-region-matched  targets equally well (2, 4). This observation 
was  unexpected,  since  the  same D-end  products  are  involved in  the  new  antigenic 
specificities formed in both strains.  This difference in response to TNP-modified H-2D  d 
products of B10.A and B10.D2 splenic lymphocytes has been attributed to a dominant H- 
2-1inked immune response (/r) gene(s), since (B10.A x B10.D2)F1 lymphocytes generated 
lytic activity toward TNP-modified H-2D d products when sensitized with  B10.A-TNP 
stimulating cells (4). 
Nabholz et al. have demonstrated that the lytic phase of an allogeneic CML 
can be blocked by antisera directed against the serological region of the target 
cell to which the responding lymphocytes were sensitized (5). A similar approach 
has been used in this study to: (a) determine whether antisera directed against 
H-2  serological specificities expressed by the target cells would affect the lytic 
phase  of the TNP autologous  CML,  and  (b) independently verify by selective 
blocking with  anti-H-2K  or D-end  sera  that in the CML generated by B10.A 
splenic  lymphocytes against  TNP-modified autologous cells,  only modified K- 
end products would be involved in the lytic phase, in contrast to B10.D2 in which 
both K- and D-end products are involved in the lysis. 
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Material and Methods 
Mice.  All mice used in the experiments were males, 6-9 wk of age.  The C57BL/10 congenic 
strains and AKR/J mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. The 
A.TL,  A.TH,  and A.AL mice used for preparation of antisera were raised in our animal colony 
from  breeders  kindly provided  by  Doctors  D.  Shreffier and  C.  David,  Department  of Human 
Genetics, University of Michigan, Ann Arbor, Mich. 
In Vitro Cell Culture  and TNP Modification  of Spleen Cells.  The methods employed for the 
primary 5-day in vitro CML sensitization and the TNP modification of stimulating and target cells 
have been reported previously (1, 2, 4). 
Blocking of  Effector Phase with Antisera.  A vol of 10/~l containing 5 x  104 TNP-modified '~lCr- 
labeled target cells was preincubated for 30 min at 37°C with 20 ~l of undiluted normal sera or 
alloantisera.  Based  on  their  known  cytotoxic  titers  for  the  specificities being  studied,  these 
antisera were in antibody excess under the experimental conditions used. The sera were absorbed 
on TNP-modified  spleen cells of the strain of origin in order to remove any natural anti-TNP 
antibody. 5 x  106 effector cells in a vol of 20/~l were then added to the target cell-antisera mixture, 
and this was incubated for 3.5 h  at 37°C in a  CO2 atmosphere for the 5~Cr-release assay (1,  2). 
Alloantisera.  The antisera used in this study were prepared by immunization of appropriate 
groups of animals with skin grafts and lymphoid cells as previously described (6).  The following 
sera  were  used  in this study:  B10.BR  anti-C57BL/10 (kkkkkk  abbbbbb); ~ B10.BR  anti-B10.D2 
(kkkkkk adddddd);  B10.D2 anti-B10.BR (dddddd  akkkkkk); A.TL anti-A.AL (skkkkd akkkkkd); 
A.TH anti-A.TL (sssssd askkkkd); (C57BL/10 x  A/J)F~ anti-B10.D2 ([bbbbbb x  kkkddd] adddddd); 
B10.BR anti-B10.A (kkkkkk akkkddd);  and B10.A anti-C57BL/10 (kkkddd  abbbbbb).  Anti-TNP, 
kindly provided by Dr. Pierre Henkart, Immunology Branch, National Cancer Institute, Bethesda, 
Md., was the immunoglobulin fraction of anti-TNP-keyhole limpet hemocyanin serum prepared 
in C57BL/10 mice. 
Results and Discussion 
The results  shown in Table I  verify that B10.A effector cells generated by 
sensitization  with TNP-modified autologous cells lyse B10.A-TNP  (homology 
throughout H-2) and B10.BR-TNP (H-2 homology at K,/-A,  and I-B) targets 
equally  well,  but  not  B10.D2-TNP  (H-2 homology  at  I-C,  S,  and  D),  nor 
C57BL/10-TNP  (no H-2-region homology) targets.  However, B10.D2  effectors, 
generated by sensitization  with  TNP-modified autologous spleen cells,  lysed 
both B 10. D2-TNP (homology throughout H-2) and B10. A-TNP (H-2 homology at 
I-C, S, and D) targets, but not B10.BR-TNP nor C57BL/10-TNP (no H-2-region 
homology). 
The lympholysis of B10.A-TNP targets by effectors generated from sensitiza- 
tion of B10.A and B10.D2 lymphocytes with either TNP-modified autologous or 
allogeneic spleen cells and the effect of various antisera are shown in Table II. A 
complete inhibition of lysis by B10.D2 effectors was obtained when the B10.A- 
TNP  targets  were preincubated with sera directed against D-end serological 
specificities (section A). In contrast, this antiserum had no effect on the lysis of 
targets by B10.A effector cells. Antisera directed against products of  K, I-A, and 
I-B regions of B10.A target cells had no effect on the lysis by B10.D2 effectors, 
but significantly inhibited the lysis by B10.A effector cells. The data in the lower 
part of section A demonstrate that these sera have only minimal effects on the 
lytic capacity of effector cells of these strains directed against H-2  b alloantigens. 
It is interesting to note that the only appreciable decrease in lysis seen in these 
l Lowercase  letters  indicate  haplotype  of  origin  of  the  six  presently  defined  regions  and 
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TABLE  I 
Differential  Cytotoxic Response  Potential of B10.A- and BlO.D2-Responding Lymphocytes to 
TNP-Modified H-2D End Products 
Responding cell  Stimulating 
cells 
% Specific lysis ±  SE on target cells 
B10.A-TNP  B10.D2oTNP  B10.BR-TNP  C57BL/10-TNP 
kkkddd-TNP*  dddddd-TNP  kkkkkk-TNP  bbbbbb-TNP 
SlO.Akkkddd  B10.A-TNP  36.0 ±  3.0(allH-  0.0  ±  1.5  (I-C,  31.8  ±  3.8 (K, I-  -8.8 ±  4.0 
kkkddd-TNP  2)$  S, D)  A, I-B)  (none) 
B10.D2-TNP  11.6  ±  4.0  (/-C,  21.4 ±  3.7 (allH-  3.3 ±  2.2 (none)  4.4 ±  2.7  B10. D2 dddddd  fk/dd44.  TNP  S, D)  2)  (none) 
* Lowercase letters  indicate  the  haplotype  of origin of the  six presently defined  regions and subregions of the H-2 
complex, K, I-A, I-B, I-C, S, and D  (7). 
t  Target cell 1"1-2 region common to responding cell and stimulating  cell. 
allogeneic  controls  occurred  when  a  possible D-region  public  specificity was 
blocked and when B10.D2 but not B10.A was the effector cell donor. 
The  differential  effect of the  anti-H-2 d serum  on the  inhibition  of lysis by 
B10.A and B10.D2 effector cells can be attributed exclusively to differences in 
the lytic potential of the effector cells, since the same antiserum and target cells 
were used in both cases. These results demonstrate that inhibition was observed 
only in the presence of antisera directed against those modified H-2 specificities 
toward which the effectors were sensitized,  and  verify that  B10.A responding 
lymphocytes are nonresponders to TNP-modified autologous D-end components. 
The  selectivity of the H-2  components involved in the blocking of the  lytic 
phase  of CML by antibodies was further  analyzed for B10.A responding cells 
sensitized  against  TNP-modified autologous cells and  assayed on  B10.A-TNP 
target  cells.  The  data  presented  in  section  B  show that  antiserum  directed 
against the H-2K  k region (A.TL anti-A.AL) can completely inhibit the lysis of 
B10.A effectors on B10.A-TNP target cells, whereas sera directed against (I-A to 
S)k-region  products  (A.TH  anti-A.TL)  or  against  (I-C  to  D)  d  (B10.BR  anti- 
B10.D2) do not affect lympholysis. As shown in the controls in the lower part of 
section  B,  these  sera  directed  against  H-2  antigens  expressed  on  effectors 
sensitized  against  H-2  b  alloantigens  did  not  reduce  the  lysis  measured  on 
C57BL/10-TNP target cells. 
Since  B10.D2  cells sensitized  against  autologous TNP-modified spleen cells 
appeared to react against both (K, I-A, I-B)  d- and H-2Dd-modified components, 
the influence of sera directed against products of the whole H-2 d complex, (K, I- 
A, I-B)  d regions,  (I-C,  S,  D)  ~ regions,  and  against  the  shared I-A  subregion 
specificity Ia.8  (6) were examined  in  the  lytic phase  assayed on B10.D2-TNP 
spleen  targets.  The  results,  shown  in  section  C  of Table  II,  indicate  that  a 
complete inhibition of the lympholysis by B10. D2 cells sensitized against autolo- 
gous TNP-modified cells was obtained only in the presence  of serum  directed 
against products of the whole H-2 complex. Sera directed against either (K, I-A, 
I-B)  d  or  (I-C,  S,  D)  d  regions  of  the  unmodified  targets  partially  inhibited 
lympholysis, whereas serum against the Ia.8 specificity had no significant effect 
on  CML.  Controls  indicating  that  none  of these  sera  affect  lympholysis by 
B10.D2 effectors sensitized against H-2  k alloantigens when assayed on B10.BR- T
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TNP spleen  targets  are  also  shown. It  is  noteworthy that  anti-Ia  sera (sections  B 
and C, Table If) had no appreciable effect  on lysis  of these splenic targets, 
despite the fact  that at least  50% of  spleen cells  express Ia antigens (6). 
The F(ab)2  fragment of  antibodies directed  against  TNP protect  TNP-modified 
targets from complement-dependent lysis  by antisera directed against the un- 
modified H-2 specificities  (A.-M. Schmitt-Verhulst,  unpublished observation). 
This observation suggests that at  least  some of  the  TNP groups are  closely  asso- 
ciated  with unaltered H-2 alloantigens.  Therefore, we tested  whether anti-TNP 
antibodies would inhibit  the lysis  of  TNP-modified targets  by effector  cells  gen- 
erated by sensitization  with either TNP-modified autologous or unmodified al- 
logeneic sensitizing  cells.  The data,  summarized in  Table If,  section  D, indicate 
that the lytic  phase of  the CML  of  B10.BR effectors  sensitized  by TNP-modified 
autologous cells  is  partially  inhibited  by sera directed  against H-2  k  alloantigens 
and is  completely inhibited  by serum directed  against  TNP. The lysis  measured 
on C57BL/10-TNP  targets by B10.BR effectors  sensitized  against unmodified 
H-2  b  alloantigens was not inhibited by the serum directed  against the alloanti- 
gens of  the effector  cells  (H-2k),  but was completely blocked by antisera directed 
against the TNP present on the target cells.  It is  also  shown in this  section,  in 
which B10.BR effector  cells  are sensitized  against  unmodified H-2  b  alloantigens, 
that the inhibition  of  the allogeneic  effector  phase by anti-TNP serum required 
the  presence  of  TNP on  the  target  cells.  A partial  inhibition  was also  obtained  by 
serum directed against the H-2  b alloantigens. These latter  results using anti- 
TNP sera are  compatible with  the interpretation  that  antibodies attached to  the 
haptenic moiety protect  the alloantigens from attack by the effector  cells. 
The H-2K and H-2D antigens are known to be located on separate molecules 
(8) and to migrate independently on the cell  surface (9).  The blocking of the 
effector  phase of  the TNP-autologous CML  with anti-H-2K, anti-H-2D, or anti- 
TNP  sera suggests that some TNP  groups are physically closer  to the serolog- 
ically  defned antigens than K- and D-region antigens are to each other. 
It has recently been found that H-2K or H-2D  antigens are functionally 
associated  with the lysis  by cells  sensitized  against non-H-2 alloantigens (10)  or 
sex-associated  differences  (11).  In the latter  case,  K- and/or  D-region homology 
was required between stimulator and target cells,  but not between effector  and 
target  cells  for  lysis  to  occur  (12).  Ifa  unitarian  model is  to  be  proposed for  H-2K- 
or H-2D-restricted lysis  observed for stimulations involving TNP  modification 
(1-4),  viral  infection  (13-15),  and the non-H-2 differences  (10,  11),  at least  two 
possibilities  can be considered: (a) all of  the above examples involve activation 
of T-cell clones recognizing modified H-2 components; or (b) TNP  and viral 
modifications,  as well as the other examples (10,  11),  do not involve recognition 
of  altered  H-2 products, but lysis  is  effective  only on targets sharing H-2K or H- 
2D antigens with the stimulating cells  by some as yet undefined mechanism. 
The second possibility  seems unlikely, since  the recognition unit of  the effector 
cell  is  blocked only by  TNP- or  viral-modified  (2, 13),  H-2-matched cells,  and not 
by modified congenic cells  that  do not share serological  region products with the 
stimulating cells.  Furthermore, the examples presented in this  report indicate 
that antibodies to  the same D-region antigen do or do not block lysis  depending 216  SCHMITT-VERHULST  ET  AL.  BRIEF  DEFINITIVE  REPORT 
exclusively on the  source  of the  effector cell.  This observation would not be 
expected if any determinant not physically associated with H-2 were the target 
of lysis. Since a  close association between TNP and the H-2  serological region 
products  has  been  demonstrated in  this  report,  it  is  difficult to  distinguish 
between a model involving sensitization against modified H-2 products and one 
encompassing "hapten" in close association with or in the immediate environ- 
ment of cell surface H-2 products. 
Summary 
Splenic lymphocytes from B10.A and B10.D2  mice were sensitized in vitro to 
trinitrophenyl (TNP)-modified autologous spleen cells. The effector cells gener- 
ated were assayed in a  51Cr-release  assay on TNP-modified syngeneic or con- 
genic spleen target cells. Effector cells from B10.A donors lysed TNP-modified 
H-2K  k- but not H-2D~-region products, whereas B10.D2  effectors reacted with 
modified products of both the H-2K  d and H-2D  d regions.  As an independent 
confirmation that this selective K-end lysis by B10.A effector cells is due to an 
H-2-1inked responder cell defect (4), anti-H-2K  k but not anti-H-2D  d sera were 
shown to inhibit the lysis of B10.A-TNP targets by B10.A effectors. In contrast, 
anti-H-2D  d sera inhibited the lysis of B10.A-TNP targets by B10.D2  effectors. 
Anti-Ia antibodies had no detectable effect on lysis. Anti-TNP-keyhole limpet 
hemocyanin sera  blocked  the  lysis  of TNP-modified targets,  irrespective  of 
whether the effector cells were directed against TNP-modified autologous H-2 
products  or  H-2  alloantigens.  These results independently verify that B10.A 
responding lymphocytes do not generate effector cells to TNP-modified H-2D  d 
products,  whereas  B10.D2  lymphocytes do  (4), and  suggest that  some  TNP 
groups are sterically close to (or part of) the serologically defined H-2K- and H- 
2D-region antigens. 
The  authors  are  grateful  to  Dr.  Pierre  Henkart  for  providing the  anti-TNP-keyhole limpet 
hemocyanin sera and to Judith Jaworek for preparation of the manuscript. 
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